Graft Versus Host Disease Treatment
SKU
MRR-43676CF42284
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 1.87 billion
2030
USD 3.76 billion
2024
USD 2.06 billion
CAGR
10.45%

Graft Versus Host Disease Treatment Market by Disease Type (Acute Graft Versus Host Disease, Chronic Graft Versus Host Disease), Product (Corticosteroids, Monoclonal Antibodies, Tyrosine Kinase Inhibitors), End-User - Global Forecast 2024-2030

[184 Pages Report] The Graft Versus Host Disease Treatment Market size was estimated at USD 1.87 billion in 2023 and expected to reach USD 2.06 billion in 2024, at a CAGR 10.45% to reach USD 3.76 billion by 2030.

Graft Versus Host Disease Treatment Market
To learn more about this report, request a free PDF copy
Graft Versus Host Disease Treatment Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Graft Versus Host Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Graft Versus Host Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Graft Versus Host Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, ElsaLys Biotech SA, Johnson & Johnson Services, Inc., Mallinckrodt LLC, Merck KGaA, Mesoblast Limited, Neovii Pharmaceuticals AG, Novartis AG, Ocugen, Inc., Pfizer Inc, Pluristem Therapeutics Inc., Sanofi S.A., and Soligenix, Inc..

Market Segmentation & Coverage

This research report categorizes the Graft Versus Host Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Acute Graft Versus Host Disease
    • Chronic Graft Versus Host Disease
  • Product
    • Corticosteroids
    • Monoclonal Antibodies
    • Tyrosine Kinase Inhibitors
  • End-User
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Graft Versus Host Disease Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Graft Versus Host Disease Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Graft Versus Host Disease Treatment Market?
  4. What is the market share of the leading vendors in the Graft Versus Host Disease Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Graft Versus Host Disease Treatment Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Increases in air cargo revenue and tonnage to boost bulky and heavy cargo
        2. Growing number of allogeneic transplantations
        3. Rising number of patients undergoing allogeneic haematopoietic stem cell transplants
      2. Restraints
        1. Disruption through digitization and demand to speed-up the movement of goods across the globe
        2. Competition from other transport modes
        3. Clinical advancements in the treatment procedure
      3. Opportunities
        1. Growth of cargo services in emerging markets
        2. Technological developments in new aircraft technologies and the digitization
      4. Challenges
        1. Trade tensions and increasing industry regulation
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Graft Versus Host Disease Treatment Market, by Disease Type
    1. Introduction
    2. Acute Graft Versus Host Disease
    3. Chronic Graft Versus Host Disease
  7. Graft Versus Host Disease Treatment Market, by Product
    1. Introduction
    2. Corticosteroids
    3. Monoclonal Antibodies
    4. Tyrosine Kinase Inhibitors
  8. Graft Versus Host Disease Treatment Market, by End-User
    1. Introduction
    2. Hospital Pharmacies
    3. Online Pharmacies
    4. Retail Pharmacies
  9. Americas Graft Versus Host Disease Treatment Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Asia-Pacific Graft Versus Host Disease Treatment Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  11. Europe, Middle East & Africa Graft Versus Host Disease Treatment Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  12. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  13. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  14. List of Figures [Total: 22]
    1. GRAFT VERSUS HOST DISEASE TREATMENT MARKET RESEARCH PROCESS
    2. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
    3. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. GRAFT VERSUS HOST DISEASE TREATMENT MARKET DYNAMICS
    7. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
    8. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    10. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    12. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    13. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    14. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    15. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    16. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    17. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
    22. GRAFT VERSUS HOST DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  15. List of Tables [Total: 284]
    1. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    8. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    9. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ACUTE GRAFT VERSUS HOST DISEASE, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ACUTE GRAFT VERSUS HOST DISEASE, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CHRONIC GRAFT VERSUS HOST DISEASE, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CHRONIC GRAFT VERSUS HOST DISEASE, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    14. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    15. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    22. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    23. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
    29. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    30. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    31. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    32. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    33. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    34. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    35. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    36. AMERICAS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    37. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    38. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    39. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    40. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    41. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    42. ARGENTINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    43. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    44. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    45. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    46. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    47. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    48. BRAZIL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    49. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    50. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    51. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    52. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    53. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    54. CANADA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    55. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    56. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    57. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    58. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    59. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    60. MEXICO GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    61. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    62. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    63. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    64. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    65. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    66. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    67. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    68. UNITED STATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    69. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    70. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    71. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    72. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    73. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    74. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    75. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    76. ASIA-PACIFIC GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    77. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    78. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    79. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    80. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    81. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    82. AUSTRALIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    83. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    84. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    85. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    86. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    87. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    88. CHINA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    89. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    90. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    91. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    92. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    93. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    94. INDIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    95. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    96. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    97. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    98. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    99. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    100. INDONESIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    101. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    102. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    103. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    104. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    105. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    106. JAPAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    107. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    108. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    109. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    110. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    111. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    112. MALAYSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    113. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    114. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    115. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    116. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    117. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    118. PHILIPPINES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    119. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    120. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    121. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    122. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    123. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    124. SINGAPORE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    125. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    126. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    127. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    128. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    129. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    130. SOUTH KOREA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    131. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    132. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    133. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    134. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    135. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    136. TAIWAN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    137. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    138. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    139. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    140. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    141. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    142. THAILAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    143. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    144. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    145. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    146. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    147. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    148. VIETNAM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    149. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    150. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    151. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    152. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    153. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    154. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    155. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    156. EUROPE, MIDDLE EAST & AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    157. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    158. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    159. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    160. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    161. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    162. DENMARK GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    163. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    164. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    165. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    166. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    167. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    168. EGYPT GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    169. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    170. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    171. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    172. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    173. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    174. FINLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    175. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    176. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    177. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    178. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    179. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    180. FRANCE GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    181. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    182. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    183. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    184. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    185. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    186. GERMANY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    187. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    188. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    189. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    190. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    191. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    192. ISRAEL GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    193. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    194. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    195. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    196. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    197. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    198. ITALY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    199. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    200. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    201. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    202. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    203. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    204. NETHERLANDS GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    205. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    206. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    207. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    208. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    209. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    210. NIGERIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    211. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    212. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    213. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    214. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    215. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    216. NORWAY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    217. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    218. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    219. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    220. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    221. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    222. POLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    223. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    224. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    225. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    226. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    227. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    228. QATAR GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    229. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    230. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    231. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    232. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    233. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    234. RUSSIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    235. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    236. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    237. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    238. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    239. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    240. SAUDI ARABIA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    241. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    242. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    243. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    244. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    245. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    246. SOUTH AFRICA GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    247. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    248. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    249. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    250. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    251. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    252. SPAIN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    253. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    254. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    255. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    256. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    257. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    258. SWEDEN GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    259. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    260. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    261. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    262. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    263. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    264. SWITZERLAND GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    265. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    266. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    267. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    268. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    269. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    270. TURKEY GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    271. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    272. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    273. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    274. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    275. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    276. UNITED ARAB EMIRATES GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    277. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
    278. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
    279. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    280. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    281. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    282. UNITED KINGDOM GRAFT VERSUS HOST DISEASE TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    283. GRAFT VERSUS HOST DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
    284. GRAFT VERSUS HOST DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Companies Mentioned [Total: 15]
    1. AbbVie Inc.
    2. Astellas Pharma Inc.
    3. Bristol-Myers Squibb Company
    4. ElsaLys Biotech SA
    5. Johnson & Johnson Services, Inc.
    6. Mallinckrodt LLC
    7. Merck KGaA
    8. Mesoblast Limited
    9. Neovii Pharmaceuticals AG
    10. Novartis AG
    11. Ocugen, Inc.
    12. Pfizer Inc
    13. Pluristem Therapeutics Inc.
    14. Sanofi S.A.
    15. Soligenix, Inc.
Frequently Asked Questions
  1. How big is the Graft Versus Host Disease Treatment Market?
    Ans. The Global Graft Versus Host Disease Treatment Market size was estimated at USD 1.87 billion in 2023 and expected to reach USD 2.06 billion in 2024.
  2. What is the Graft Versus Host Disease Treatment Market growth?
    Ans. The Global Graft Versus Host Disease Treatment Market to grow USD 3.76 billion by 2030, at a CAGR of 10.45%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.